Uremic restless legs syndrome (RLS) and sleep quality in patients with end-stage renal disease on hemodialysis: Potential role of homocysteine and parathyroid hormone

Kidney and Blood Pressure Research

Volumn 37, Issue 4-5, 2013, Pages 458-463

  Gade, Katrin ^a   Blaschke, Sabine ^a   Rodenbeck, Andrea ^a,b   Becker, Andreas ^a   Anderson Schmidt, Heike ^a   Cohrs, Stefan ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MARTIN LUTHER KRANKENHAUS   (Germany)

Author keywords

Dialysis; Homocysteine; Parathyroid hormone; Sleep Quality; Uremic RLS

Indexed keywords

ALBUMIN; CALCIUM; CREATININE; FERRITIN; FOLIC ACID; HEMOGLOBIN; HOMOCYSTEINE; IRON; MAGNESIUM; PARATHYROID HORMONE; PHOSPHATE; UREA;

ADULT; AGED; ALBUMIN BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FERRITIN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; KIDNEY FAILURE; MAGNESIUM BLOOD LEVEL; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SLEEP QUALITY; UREA BLOOD LEVEL; UREMIA; END STAGE RENAL DISEASE; MAJOR CLINICAL STUDY; UREMIC RESTLESS LEGS SYNDROME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HOMOCYSTEINE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; RENAL DIALYSIS; RESTLESS LEGS SYNDROME; SLEEP; UREMIA;

EID: 84890374904     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000355727     Document Type: Article

References (19)

1. Kavanagh D, Siddiqui S, Geddes CC: Restless legs syndrome in patients on dialysis. Am J Kidney Dis 2004;43:763-771
2. Collado-Seidel V, Kohnen R, Samtleben W, Hillebrand GF, Oertel WH, Trenkwalder C: Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis 1998;31:324-328
3. Siddiqui S, Kavanagh D, Traynor J, Mak M, Deighan C, Geddes C: Risk factors for restless legs syndrome in dialysis patients. Nephron Clin Pract 2005;101:155-160
4. Kawauchi A, Inoue Y, Hashimoto T, Tachibana N, Shirakawa S, Mizutani Y, Ono T, Miki T: Restless legs syndrome in hemodialysis patients: Health-related quality of life and laboratory data analysis. Clin Nephrol 2006;66:440-446
5. Walters AS, The International Restless Legs Syndrome Study Group: Toward a better definition of the restless legs syndrome. Mov Disord 1995;10:634-642
6. Walters AS, Le Brocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C: Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121-132
7. Riemann D, Backhaus J: Behandlung von Schlafstörungen. Psychologie Verlags Union; Weinheim 1996, pp. 33-56
8. Walker MC, Smith GN, Perkins SL, Keely EJ, Garner PR: Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol 1999;180:660-664
9. Sabbatini M, Minale B, Crispo A, Pisani A, Ragosta A, Esposito R, Cesaro A, Cianciaruso B, Andreucci VE: Insomnia in maintenance haemodialysis patients. Nephrol Dial Transplant 2002;17:852-856
10. Esposito MG, Cesare CM, De Santo RM, Cice G, Perna AF, Violetti E, Conzo G, Bilancio G, Celsi S, Annunziata F, Ianelli S, De Santo NG, Cirillo M, Livrea A: Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism. J Nephrol 2008;21:S92-S96
11. Lim LL, Dinner D, Tham KW, Siraj E, Shields R: Restless legs syndrome associated with primary hyperparathyroidism. Sleep Med 2005;6:283-285
12. Bachmann CG, Guth N, Helmschmied K, Armstrong VW, Paulus W, Happe S: Homocysteine in restless legs syndrome. Sleep Med 2008;9:388-392
13. Arnadottir M, Berg AL, Hegbrant J, Hultberg B: Influence of haemodialysis on plasma total homocysteine concentration. Nephrol Dial Transplant 1999;14:142-146
14. Agnati LF, Ferre S, Genedani S, Leo G, Guidolin D, Filaferro M, Carriba P, Casado V, Lluis C, Franco R, Woods AS, Fuxe K: Allosteric modulation of dopamine D2 receptors by homocysteine. J Proteome Res 2006;5:3077-3083
15. Paulus W, Trenkwalder C: Less is more: Pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol 2006;5:878-886
16. Wuerthele SE, Yasuda RP, Freed Freed WJ, Hoffer BJ: The effect of local application of homocysteine on neuronal activity in the central nervous system of the rat. Life Sci 1982;31:2683-2691
17. Tergau F, Wischer S, Paulus W: Motor system excitability in patients with restless legs syndrome. Neurology 1999;52:1060-1063
18. De Vriese AS, Verbeke F, Schrijvers BF, Lameire NH: Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure? Kidney Int 2002;61:1199-1209
19. Botez MI, Lambert B: Folate deficiency and restless-legs syndrome in pregnancy. N Engl J Med 1977;297:670